HIV-1 virion mobility in cervicovaginal mucus is potentially influenced by bacterial vaginosis, CVM pH and viscosity
Introduction HIV-1 viruses must traverse the cervicovaginal mucus (CVM) layer to access the Q6 target cells within and beneath the mucosal epithelia. Understanding the events upon initial contact of HIV-1 viruses with CVM may be critical in HIV-1 prevention strategies. Methods Using fluorescent microscopy, we evaluated mobility of labelled HIV-1 viruses (clade C CAP045, clade Bs CH040 and R9Bal and a recombinant clade AE 92TH023) relative to labelled control 200nm PEGylated beads in CVM from a cross-sectional cohort of 122 adult women in Nairobi, Kenya. We assessed the contribution of CVM pH, CVM viscosity, CVM microbiome, serum oestrogen and progesterone, participant age, and a range of STI including HIV-1 and BV. Results We report significant, strain specific hindrance to the mobility of HIV-1 virions in CVM relative to control 200nm PEGylated beads. Clade B virions (CH040 and R9Bal) were more hindered than clade C CAP045 and clade AE 92TH023. We report increased mobility of R9Bal and a trend towards increased mobility of CH040 in CVM from women positive for BV, which was also true for the control beads. This was also observed for CAP045 HIV-1 virions mobility in CVM with the CST IV-B microbiota which is associated with BV. Discussion Our data suggest that BV, CVM pH, and effective viscosity may be associated with differences in HIV-1 virion mobility within CVM. These findings highlight the importance of the local cervicovaginal microenvironment in influencing virion movement and provide a basis for further investigation into its role in mucosal HIV-1 susceptibility and the development of preventive interventions targeting the FGT. .
Authors
- Patrick Mwaura
- Matrona Akiso (ORCID: https://orcid.org/0000-0002-3665-9304)
- Thomas J. Hope (ORCID: https://orcid.org/0000-0001-7183-8319)
- Ann M. Carias (ORCID: https://orcid.org/0000-0003-1305-254X)
- Michael D. McRaven (ORCID: https://orcid.org/0000-0002-3098-1394)
- Sarah Joseph (ORCID: https://orcid.org/0000-0001-9603-574X)
- Marianne Mureithi (ORCID: https://orcid.org/0000-0001-9119-3167)
- Janet Kombo
- Omu Aggrey Anzala (ORCID: https://orcid.org/0000-0001-5186-1415)
Institutions
- Northwestern University (US)
- University of Nairobi (KE)
- Kenya AIDS Vaccine Initiative (KE)
- Imperial College London (GB)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1964429
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00